Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Pharmaceutical Coating Equipment Market Size & Growth Forecast 2027–2036, By Segments (Product Type, Technology), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 14570| Published Date: Jul-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Pharmaceutical Coating Equipment Market size was over USD 1.03 billion in 2026 and is likely to grow at a 4.94% CAGR between 2027 and 2036, surpassing USD 1.67 billion by 2036. The industry revenue for 2027 is assessed at USD 1.07 billion.

Base Year Value (2025)
USD 968.62 Million
CAGR (2026-2035)
5.3%
Forecast Year Value (2035)
USD 1.62 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Pharmaceutical Coating Equipment Market Intelligence Snapshot

Regional Market Dynamics

  • North America captured 43.57% of the market in 2026, driven by a strong pharmaceutical manufacturing base, regulated production facilities, and ongoing investment in process quality and coating consistency.
  • Asia Pacific is projected to grow at a 5.99% CAGR as pharmaceutical manufacturing capacity expands and producers increasingly adopt automated, higher-throughput coating systems to improve production efficiency.

Segment Momentum

  • Fluidized bed coaters held a 43.46% share in 2026 by combining coating, drying, and uniform application in one process, helping manufacturers achieve consistent, scalable, and efficient production.
  • Organic film coating is expanding fastest because manufacturers increasingly require specialized solvent-based coating performance to meet formulation compatibility, finish quality, and specific processing requirements.

Market Expansion Drivers

  • Pharmaceutical industry expansion and rising R&D investment accelerating coating equipment demand.
  • Growing generics production and tablet formulation demand increasing coating equipment utilization.
  • Adoption of automated and continuous coating technologies improving manufacturing efficiency and scalability.

Leading Market Participants

  • Leading companies in the pharmaceutical coating equipment market include GEA Group AG (Germany), Syntegon Technology GmbH (Germany), Glatt GmbH (Germany), ACG Group (India), I.M.A. Industria Macchine Automatiche S.p.A. (Italy), L.B. Bohle Maschinen und Verfahren GmbH (Germany), Romaco Holding GmbH (Germany), Freund-Vector Corporation (United States), DIOSNA GmbH (Germany), Ohara Technologies Inc. (Canada).

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 1.03 billion
  • 2027 Estimated Market Size: USD 1.07 billion.
  • Projected Market Size: USD 1.67 billion by 2036
  • Growth Forecast: 4.94% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Fluidized Bed Coater (Product Type) | Film Coating (Technology)
  • Emerging Opportunity Segment: Fluidized Bed Coater (Product Type) | Organic Film Coating (Technology)
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Pharmaceutical industry expansion and rising R&D investment accelerating coating equipment demand

Expansion of pharmaceutical manufacturing and increasing research and development activity will drive the pharmaceutical coating equipment market growth as manufacturers require specialized systems for producing and developing coated dosage forms. Greater production activity increases equipment requirements across manufacturing operations, while R&D investment supports the development and refinement of formulations that depend on controlled coating processes. This combination is strengthening demand for equipment capable of supporting pharmaceutical production requirements.

Growing generics production and tablet formulation demand increasing coating equipment utilization

Rising generics production and expanding tablet formulation activity are increasing utilization within the pharmaceutical coating equipment market. Coating processes are important for manufacturers seeking to develop tablets with controlled release characteristics, improved stability, and suitable appearance or handling properties. As pharmaceutical producers expand tablet-based product portfolios, greater manufacturing throughput requires dependable coating systems that can accommodate recurring formulation and production needs.

Adoption of automated and continuous coating technologies improving manufacturing efficiency and scalability

Manufacturers are increasingly adopting automated and continuous coating technologies to improve production efficiency, consistency, and scalability, supporting the pharmaceutical coating equipment market. Automated systems can reduce reliance on manual intervention while enabling more controlled processing across coating operations. Continuous approaches can further support streamlined manufacturing workflows and production scalability, making advanced equipment increasingly relevant for pharmaceutical facilities focused on efficient and repeatable tablet processing.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Growth in pharmaceutical production 1.50% Short term (≤ 2 yrs) North America, Europe (spillover: Asia Pacific) Medium Fast
Adoption of coating automation technologies 1.00% Medium term (2–5 yrs) Europe, Asia Pacific (spillover: North America) Medium Moderate
Development of eco-friendly coating solutions 0.80% Long term (5+ yrs) North America, Europe (spillover: Asia Pacific) High Slow
Pharmaceutical industry expansion and rising R&D investment accelerating coating equipment demand 2.40% High North America, Europe High Mid Term
Growing generics production and tablet formulation demand increasing coating equipment utilization 2.20% High Global High Mid Term
Adoption of automated and continuous coating technologies improving manufacturing efficiency and scalability 1.80% Moderate Asia Pacific, Europe Medium Long Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
43.57% Market Share in 2026

North America (Largest Region)

North America dominated the pharmaceutical coating equipment market with a 43.57% share in 2026, supported by a mature pharmaceutical manufacturing base and strong demand for efficient, controlled drug-production processes. Coating equipment is essential for applying functional or protective layers to pharmaceutical products, helping manufacturers achieve consistent product quality and desired release characteristics. The region's focus on manufacturing efficiency, process automation, quality assurance, and compliance with rigorous production standards encourages investment in advanced coating technologies. Continued development of sophisticated drug formulations and modernization of manufacturing facilities further sustain demand for reliable and precise coating systems.

Asia Pacific (Fastest-Growing Region)

Asia Pacific represents the fastest-growing region for the pharmaceutical coating equipment market, driven by expanding pharmaceutical manufacturing capacity, rising healthcare demand, and increasing investment in production infrastructure. The region's growing role in drug manufacturing is encouraging facilities to adopt modern equipment capable of supporting consistent coating quality and efficient production workflows. Greater emphasis on regulatory compliance, process standardization, and manufacturing automation is also accelerating technology adoption. As pharmaceutical producers expand their capabilities and move toward more sophisticated formulations, demand for advanced coating equipment is expected to strengthen across the regional manufacturing landscape.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Precision Process Engineering

Germany emphasizes pharmaceutical coating equipment designed for reproducible performance, process control, and equipment reliability. German manufacturers invest in engineering-focused solutions that strengthen quality assurance while supporting high-value pharmaceutical production.

France 🇫🇷

Compliance-Focused Equipment

France favors pharmaceutical coating equipment that supports stringent manufacturing standards and reliable batch performance. French producers increasingly invest in systems that improve operational efficiency while maintaining consistent coating quality across production lines.

Italy 🇮🇹

Specialty Manufacturing Capability

Italy supports pharmaceutical coating equipment tailored for specialty drug production and flexible manufacturing environments. Italian manufacturers seek technologies that optimize coating precision, reduce material waste, and simplify equipment maintenance.

Japan 🇯🇵

High-Quality Formulation Support

Japan values coating equipment capable of delivering precise film application for complex pharmaceutical formulations. Japanese manufacturers focus on operational stability, efficient cleaning systems, and equipment designs that minimize production variability.

South Korea 🇰🇷

Flexible Production Expansion

South Korea is expanding pharmaceutical manufacturing capabilities with coating equipment suited for diverse product portfolios. Companies prioritize automation, rapid product changeovers, and process monitoring technologies that improve manufacturing efficiency and product quality.

United States 🇺🇸

Advanced Manufacturing Efficiency

The U.S. pharmaceutical industry adopts coating equipment that improves production flexibility, process automation, and product consistency. Manufacturers increasingly prioritize scalable technologies supporting continuous manufacturing, regulatory compliance, and efficient formulation development.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Pharmaceutical Coating Equipment Market Share (%), by Product Type, 2026

Fluidized Bed Coater
Perforated Coating Pan
Standard Coating Pan

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Product Type Segment Analysis: Fluidized Bed Coater (Largest & Fastest-Growing Segment)

The fluidized bed coater segment held the largest share of the pharmaceutical coating equipment market at 43.46% in 2026 and is also the fastest-growing segment. Its strong position is supported by the ability of fluidized bed coating systems to provide efficient and uniform coating of pharmaceutical particles, tablets, and other dosage forms while supporting controlled release and improved product stability. These systems are increasingly valued for their process efficiency, consistent coating quality, and suitability for modern pharmaceutical manufacturing requirements. Growing emphasis on precise drug delivery, production efficiency, and stringent quality standards further strengthens demand for fluidized bed coating equipment across pharmaceutical production environments.

Technology Segment Analysis: Film Coating (Largest Segment) vs Organic Film Coating (Fastest-Growing Segment)

The film coating segment accounted for the largest share of the pharmaceutical coating equipment market at 46.22% in 2026. Its established use in pharmaceutical manufacturing is driven by the need to improve tablet appearance, protect active ingredients, mask unpleasant tastes, and support controlled drug release. Film coating also provides manufacturers with flexibility in achieving consistent surface properties and dosage performance, making it a widely adopted technology across solid oral dosage production.

Organic film coating is the fastest-growing segment, supported by its ability to provide effective and uniform protective layers while accommodating specialized formulation requirements. Demand is encouraged by pharmaceutical manufacturers seeking coating solutions that enhance product stability, appearance, and functional performance. Increasing formulation complexity and the continued development of advanced oral dosage forms are also supporting greater adoption of organic film coating technologies.

Segment Sub-Segment Largest Segment Fastest Growing
Product Type Standard Coating Pan, Perforated Coating Pan, Fluidized Bed Coater Fluidized Bed Coater Fluidized Bed Coater
Technology Sugar Coating, Film Coating, Organic Film Coating, Dip Coating, Others Film Coating Organic Film Coating
Competitive Landscape

Competitive Landscape and Market Positioning

Major players in the pharmaceutical coating equipment market:

1. GEA Group AG (Germany)

2. Syntegon Technology GmbH (Germany)

3. Glatt GmbH (Germany)

4. ACG Group (India)

5. I.M.A. Industria Macchine Automatiche S.p.A. (Italy)

6. L.B. Bohle Maschinen und Verfahren GmbH (Germany)

7. Romaco Holding GmbH (Germany)

8. Freund-Vector Corporation (United States)

9. DIOSNA GmbH (Germany)

10. Ohara Technologies Inc. (Canada)

The pharmaceutical coating equipment market is driven by rising demand for uniform drug coating and process consistency. Automation is improving production scalability and quality control efficiency. The pharmaceutical coating equipment market is also witnessing adoption of advanced process monitoring systems. Continuous engineering improvements are supporting higher precision in formulation delivery.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
GEA Group AG (Germany)
Syntegon Technology GmbH (Germany)
Glatt GmbH (Germany)
ACG Group (India)
I.M.A. Industria Macchine Automatiche S.p.A. (Italy)
L.B. Bohle Maschinen und Verfahren GmbH (Germany)
Romaco Holding GmbH (Germany)
Freund-Vector Corporation (United States)
DIOSNA GmbH (Germany)
Ohara Technologies Inc. (Canada).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Hydromer Jan-25 Hydromer introduced PFAS-free hydrophilic coatings for medical devices, addressing increasing regulatory and environmental pressures in pharmaceutical manufacturing materials. The development supports safer and more sustainable coating alternatives while maintaining functional performance requirements for device lubrication and biocompatibility in medical applications.
Hydromer Jun-24 Hydromer launched HydroThrombX, an upgraded thromboresistant coating designed to improve performance in medical device applications. The product enhances material functionality in reducing thrombosis risk and reflects ongoing innovation in high-performance coating technologies for vascular and implantable medical devices.
Harland Medical Systems Sep-23 Harland Medical Systems opened a new office in Caesarea, Israel, to expand its international operational footprint. The expansion strengthens the company’s global presence in medical coating technologies and supports improved regional access to pharmaceutical and medical device manufacturers requiring coating solutions.
Biocoat, Inc. Feb-23 Biocoat introduced HYDAK UV, an ultraviolet-curable version of its hydrophilic coating technology designed for medical device applications. The development enhances coating performance and processing flexibility, supporting improved manufacturing efficiency in device surface modification and expanding the company’s advanced material coating portfolio.
Biocoat, Inc. Mar-22 Biocoat expanded into hydrophilic dip coating equipment design and delivery through the launch of its EMERSE product line. The initiative extends the company’s capabilities beyond coating materials into equipment solutions, strengthening its integration across medical device coating workflows and enhancing its position in advanced surface treatment technologies.
Colorcon Inc. Oct-21 Colorcon acquired Ideal Cures, a company specializing in tablet and capsule coating solutions for pharmaceutical applications. The acquisition strengthens Colorcon’s specialty excipients and coating portfolio, enhancing its position in pharmaceutical film coating technologies and expanding its global manufacturing and supply capabilities in drug formulation materials.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Pharmaceutical Coating Equipment Market — Custom Segments

Segment Sub-Segment
End User Pharmaceutical Manufacturers, Contract Manufacturing Organizations, Academic & Research Institutions
Dosage Form Tablets, Capsules, Multiparticulates, Other Solid Dosage Forms
Automation Level Manual, Semi-Automated, Fully Automated

Pharmaceutical Coating Equipment Market — Custom

Custom Chapter Custom Details
Pharmaceutical Manufacturing Modernization Analysis
  • Manufacturing Technology Transformation in Pharmaceutical Production
  • Equipment Upgrade Priorities Across Drug Manufacturers
  • Operational Efficiency Improvement Opportunities
  • Future Evolution of Pharmaceutical Manufacturing
Continuous Coating Technology Adoption Assessment
  • Shift Toward Continuous Pharmaceutical Processing
  • Adoption Drivers for Advanced Coating Technologies
  • Implementation Challenges and Production Benefits
  • Future Technology Adoption Pathways
Contract Manufacturing Demand Assessment
  • Growth of Outsourced Pharmaceutical Production
  • Equipment Requirements Across CDMO Facilities
  • Manufacturing Capacity Expansion Opportunities
  • Future Demand Trends in Contract Manufacturing

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

What is the market valuation of pharmaceutical coating equipment?

The market size of pharmaceutical coating equipment in 2027 is calculated to be USD 1.07 billion.

What is the forecasted size of the pharmaceutical coating equipment industry?

Pharmaceutical Coating Equipment Market size was over USD 1.03 billion in 2026 and is likely to grow at a 4.94% CAGR between 2027 and 2036, surpassing USD 1.67 billion by 2036.

How is the adoption of fluidized bed coating systems influencing efficiency in pharmaceutical manufacturing operations?

Fluidized bed coaters improve coating uniformity while integrating drying and processing steps, reducing handling complexity. This supports scalable production with more consistent batch quality, making them increasingly central to efficient solid dosage manufacturing workflows.

What is driving the shift toward automated and organic film coating technologies in pharmaceutical production?

Automation improves process control, consistency, and throughput, while organic film coating supports specialized formulation needs. Together, these advances align with manufacturers’ focus on scalable, efficient coating processes and improved product performance across production lines.

Why is the fluidized bed coater the leading product type in the pharmaceutical coating equipment market?

Fluidized bed coaters held a 43.46% share in 2026 by combining coating, drying, and uniform application in one process, helping manufacturers achieve consistent, scalable, and efficient production.

Why is organic film coating the fastest-growing technology in the pharmaceutical coating equipment market?

Organic film coating is expanding fastest because manufacturers increasingly require specialized solvent-based coating performance to meet formulation compatibility, finish quality, and specific processing requirements.

Why does North America hold the largest share of the pharmaceutical coating equipment market?

North America captured 43.57% of the market in 2026, driven by a strong pharmaceutical manufacturing base, regulated production facilities, and ongoing investment in process quality and coating consistency.

What is driving pharmaceutical coating equipment demand in Asia Pacific?

Asia Pacific is projected to grow at a 5.99% CAGR as pharmaceutical manufacturing capacity expands and producers increasingly adopt automated, higher-throughput coating systems to improve production efficiency.

Which companies dominate the pharmaceutical coating equipment landscape?

Leading companies in the pharmaceutical coating equipment market include GEA Group AG (Germany), Syntegon Technology GmbH (Germany), Glatt GmbH (Germany), ACG Group (India), I.M.A. Industria Macchine Automatiche S.p.A. (Italy), L.B. Bohle Maschinen und Verfahren GmbH (Germany), Romaco Holding GmbH (Germany), Freund-Vector Corporation (United States), DIOSNA GmbH (Germany), Ohara Technologies Inc. (Canada).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →